Gevorg Tamamyan – Launching Hemostasis Today, The New Voice in Hemostasis and Thrombosis
Gevorg Tamamyan, Co-founder and Editor in Chief of OncoDaily, shared an honoring post on LinkedIn:
“In 2 years OncoDaily became the leading news outlet of oncology, opened the doors for everyone and became the voice of oncology. Now the time is for the Hemostasis Today! Hemostasis Today (HT) will be the daily voice of hemostasis and thrombosis world.
We started Hemostasis Today just 2 months ago and in 2 months it became already a very popular platform in the community. Below is the total engagement metrics on LinkedIn for the last 30 days, comparing its activity with leading global news and scientific publication pages.
Hemostasis Today is a proud member of OncoDaily family.
Soon we will launch also the Hemostasis Today TV, Hemostasis Today Magazine and the Medical Journal.
If you are interested to be part of our journey, please, connect with us. We will be more than happy for that.”
Stay informed with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?